Release Date: 05/05/09 09:36 Summary: Response to ASX Price and Volume Query Price Sensitive: Yes Download Document 501.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%